Elysia Group, LLC, a Health Economics and Outcomes Research consultancy, which Bruce co-founded in 2014. He worked with over 20 biotech and pharmaceutical companies to provide market access and health economic solutions in the United States, Asia, and emerging markets. His experience spans dozens of therapeutic areas and indications across products generating billions of dollars annually.